The current study was extended to investigate the correlation between MACC1 expression and CD163+ tumor-associated macrophages, CD56+ natural killer cells, and CD8+ cytotoxic T lymphocytes within BC tumor microenvironment. Here, CD163 is linked to breast cancer.